Aim-Hi Accelerator Fund Inc, operating under the name Aim Hi Translational Research Inc, is located in Rockville, MD. The organization was established in 2019. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Aim HI Translational Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Aim HI Translational Research Inc generated $3.3m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 2 years, the organization has seen revenues fall by an average of (24.2%) each year. All expenses for the organization totaled $6.5k during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (72.6%) per year over the past 2 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE AIM-HI ACCELERATOR FUND IS AN INDEPENDENT 501(C)(3) NON-PROFIT ORGANIZATION, ESTABLISHED WITH AN INITIAL GRANT FROM THE NATIONAL FOUNDATION FOR CANCER RESEARCH WITH THE VISION TO ACCELERATE THE TRANSLATION OF CANCER DRUG DISCOVERIES BY INVESTING IN SEED-STAGE COMPANIES. IT IS A NEW PARADIGM THROUGH VENTURE PHILANTHROPY TO FUND START-UP ONCOLOGY COMPANIES THAT COMMERCIALIZE INNOVATIVE LABORATORY BREAKTHROUGHS WHICH CAN POTENTIALLY SAVE CANCER PATIENTS' LIVES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
LEVERAGING IMMEDIATELY DEPLOYABLE VENTURE PHILANTHROPY FUNDING TO PROVIDE SEED FUNDING AND SUSTAINABLE IMPACT INVESTMENT FOR ONCOLOGY START-UPS TO BRIDGE THE "VALLEY OF DEATH" AND BRING INNOVATIVE NEW THERAPIES, DIAGNOSTICS AND CANCER PREVENTION TO PATIENTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Sujuan Ba President/ceo | Officer | 15 | $0 |
Kwok Leung Treasurer/secretary | Officer | 15 | $0 |
Mark Baran Director | Trustee | 1.5 | $0 |
Matt Tremblay Vice Chairman | Trustee | 1.5 | $0 |
Charlie Weatherspoon Chairman Of The Board | Trustee | 2 | $0 |
Franklin Salisbury Jr Director | Trustee | 1.5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $3,347,719 |
Noncash contributions included in lines 1a–1f | $2,225,065 |
Total Revenue from Contributions, Gifts, Grants & Similar | $3,347,719 |
Total Program Service Revenue | $0 |
Investment income | $4 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,347,723 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $199 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $5,040 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $825 |
Royalties | $0 |
Occupancy | $0 |
Travel | $460 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $6,524 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $388,825 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $9,230,897 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $9,619,722 |
Accounts payable and accrued expenses | $630 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $630 |
Net assets without donor restrictions | $9,619,092 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $9,619,722 |
Over the last fiscal year, we have identified 1 grants that Aim-Hi Accelerator Fund Inc has recieved totaling $3,425,000.
Awarding Organization | Amount |
---|---|
Cancer Research America Nfcr Inc Rockville, MD PURPOSE: TRANSLATIONAL | $3,425,000 |
Organization Name | Assets | Revenue |
---|---|---|
Prevent Cancer Foundation Alexandria, VA | $19,123,889 | $9,204,793 |
Friends Of Cancer Research Washington, DC | $13,600,990 | $5,525,309 |
For Petes Sake Cancer Respite Foundation Plymouth Meeting, PA | $5,811,462 | $3,990,620 |
Sbarro Health Research Organization Inc Philadelphia, PA | $1,818,007 | $1,444,668 |
Brem Foundation To Defeat Breast Cancer Inc Silver Spring, MD | $741,999 | $846,932 |
Chance For Life Alexandria, VA | $1,211,933 | $982,944 |
The Leonard And Madlyn Abramson Family Cancer Research Institute Philadelphia, PA | $9,146,626 | $1,244,628 |
The Brassica Foundation For Chemopr Otection Research Inc Mclean, VA | $239,523 | $198,133 |
National Breast Cancer Coalition Washington, DC | $46,260 | $255,959 |
Paint Pittston Pink Pittston, PA | $6,994 | $212,265 |
Djerassi Cancer Research Foundation Philadelphia, PA | $460,172 | $48,098 |
Kentucky Society Of Clinical Oncology Inc Severna Park, MD | $167,543 | $209,834 |